U.S. FDA approves Amgen drug for prevention of migraines



(Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults.





Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*